Connor, Clark & Lunn Investment Management Ltd.
Position in CDNA — CareDx, Inc.
CIK 1596800
VANCOUVER, A1
Position in CDNA
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$7,643,899
+$1,217,523 QoQ
Shares Held
268,207
-27.5% QoQ
Ownership
0.518%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#45
of 225 holders
Holding Since
Dec 2020
20 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in CDNA Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Connor, Clark & Lunn Investment Management Ltd. holds $189,818,037 across 16 Diagnostics & Research names. CDNA ranks #9 (4.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MEDP |
Medpace Holdings, Inc.
|
110,353 | $58,441,845 | |
| 2 | GH |
Guardant Health, Inc.
|
215,395 | $32,315,711 | |
| 3 | DHR |
Danaher Corp /De/
|
114,010 | $21,716,624 | |
| 4 | TMO |
Thermo Fisher Scientific Inc.
|
36,269 | $18,183,825 | |
| 5 | NEO |
Neogenomics Inc
|
802,597 | $11,709,889 | |
| 6 | RVTY |
Revvity, Inc.
|
87,145 | $9,695,752 | |
| 7 | MYGN |
Myriad Genetics Inc
|
1,407,860 | $8,038,880 | |
| 8 | CSTL |
Castle Biosciences Inc
|
331,727 | $7,911,688 |
All Filings in CDNA
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $7,643,899 | 268,207 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $6,426,376 | 370,183 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $12,529,824 | 665,065 | Shares | Sole | 2026-02-10 | |
| 2025-09-30 | $15,555,022 | 1,069,809 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $21,148,298 | 1,082,308 | Shares | Sole | 2025-08-07 | |
| 2025-03-31 | $17,813,545 | 1,003,580 | Shares | Sole | 2025-05-12 | |
| 2024-12-31 | $18,737,967 | 875,197 | Shares | Sole | 2025-02-10 | |
| 2024-09-30 | $21,760,483 | 696,893 | Shares | Sole | 2024-11-08 | |
| 2024-06-30 | $6,067,120 | 390,671 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $2,771,879 | 261,745 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $2,019,780 | 168,315 | Shares | Sole | 2024-02-09 | |
| 2023-09-30 | $969,878 | 138,554 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $1,644,248 | 193,441 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $1,724,590 | 188,686 | Shares | Sole | 2023-05-10 | |
| 2022-12-31 | $1,291,452 | 113,186 | Shares | Sole | 2023-02-10 | |
| 2022-09-30 | $1,475,038 | 86,665 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $497,648 | 23,168 | Shares | Sole | 2022-08-05 | |
| 2021-06-30 | $2,958,109 | 32,322 | Shares | Sole | 2021-08-12 | |
| 2021-03-31 | $1,693,602 | 24,873 | Shares | Sole | 2021-05-13 | |
| 2020-12-31 | $783,039 | 10,808 | Shares | Sole | 2021-02-16 | |
| No filing history on record for this holder in this stock. | ||||||